Armata Pharmaceuticals (ARMP) Other financing activities (2015 - 2021)
Armata Pharmaceuticals (ARMP) posted Other financing activities of -$1.4 million for Q1 2021, down 427.31% sequentially from $432000.0 in Q4 2020, and down 41.4% YoY from -$2.4 million in Q1 2020.
Armata Pharmaceuticals (ARMP) Other financing activities (2015 - 2021) Analysis & Trends
Armata Pharmaceuticals has reported Other financing activities for 6 years, with the latest figure at -$1.4 million in Q1 2021.
- Quarterly Other financing activities fell 41.4% year-over-year to -$1.4 million in Q1 2021, while the trailing twelve-month figure through Dec 2021 was -$1.4 million (down 148.94% YoY) and the FY2022 annual result came in at $500000.0, up 135.36% from the prior year.
- Other financing activities retreated to -$1.4 million in Q1 2021 per ARMP's latest filing, from $432000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $432000.0 in Q4 2020 and troughed at -$1.4 million in Q1 2021.
- A 5-year average of -$316666.7 and a median of $3000.0 in 2018 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2019 and 2020: Other financing activities sank 33433.33% in 2019, then changed 0.0% in 2020.
- Over 5 years, Other financing activities stood at $99000.0 in 2017, then plunged by 294.95% to -$193000.0 in 2018, then plunged by 418.13% to -$1.0 million in 2019, then jumped by 143.2% to $432000.0 in 2020, then slumped by 427.31% to -$1.4 million in 2021.
- According to Business Quant data, Other financing activities over the past three periods registered -$1.4 million, $432000.0, and -$1.0 million for Q1 2021, Q4 2020, and Q1 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Armata Pharmaceuticals | 162.98 Mn | 138.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | -1.41 Mn |
| Mar 31, 2021 | -1.41 Mn |
| Dec 31, 2020 | 432,000.00 |
| Dec 31, 2020 | 432,000.00 |
| Mar 31, 2020 | -1.00 Mn |
| Mar 31, 2020 | -1.00 Mn |
| Mar 31, 2019 | -1.00 Mn |
| Mar 31, 2019 | -1.00 Mn |
| Sep 30, 2018 | -193,000.00 |
| Sep 30, 2018 | -193,000.00 |
| Jun 30, 2018 | 195,000.00 |
| Jun 30, 2018 | 195,000.00 |
| Mar 31, 2018 | 3,000.00 |
| Mar 31, 2018 | 3,000.00 |
| Dec 31, 2017 | 99,000.00 |
| Dec 31, 2017 | 99,000.00 |
| Sep 30, 2017 | 28,000.00 |
| Sep 30, 2017 | 28,000.00 |
| Sep 30, 2015 | -1,000.00 |
| Sep 30, 2015 | -1,000.00 |